THINKCYTE
  • Science
  • Platform
    • Cell Therapy
    • Drug Discovery
  • Resources
    • Documentation
    • Publications
  • Company
    • Mission
    • Team
    • News
    • Careers
Get in touch

News

  • All
  • Events
  • Information
  • Press
日本語はこちら
  • Press

    Jan 23, 2023

    ThinkCyte broadens Advisory Board with the appointments of Dr. Diether Recktenwald, Ph.D. and Dr. Bo Saxberg, M.D. Ph.D.

  • Press

    Dec 26, 2022

    ThinkCyte and Axcelead DDP collaborate to advance novel phenotypic drug screening methods

  • Press

    Dec 13, 2022

    PhoreMost and ThinkCyte collaborate to advance AI-based drug discovery

  • Press

    Dec 6, 2022

    Vision Care Group and ThinkCyte Announce Research Alliance in Advanced Cell Therapy

  • Press

    Jul 21, 2022

    ThinkCyte announces Premier Early Access Program for its new label-free cell characterization and sorting system

  • Press

    Jul 11, 2022

    ThinkCyte shares applications of Ghost Cytometry with industrial and academic thought leaders

  • Press

    Jun 23, 2022

    ThinkCyte Establishes Presence in the Bay Area and Strengthens Senior Management Team With Industry Veteran

  • Press

    Dec 21, 2021

    ThinkCyte’s novel label-free in-silico ghost cytometry published in eLife

  • Press

    May 19, 2021

    ThinkCyte Secures $26 Million in Series B Financing

  • Press

    May 12, 2021

    Sysmex and ThinkCyte Agree on Joint Development and Capital Alliance

  • Press

    Aug 24, 2020

    ThinkCyte Awarded NEDO PCA Grant to Advance Label-free Cell Sorting Technology for Cell Therapy

  • Press

    Jul 9, 2020

    ThinkCyte and National Cancer Center Japan Jointly Awarded AMED Grant for Isolation of Circulating Tumor Cells

  • Press

    Jul 1, 2020

    Hitachi and ThinkCyte Announce Collaboration to Develop an AI-driven Cell Analysis and Sorting System

  • Press

    May 29, 2020

    ThinkCyte Completes $15 Million Series A Financing

  • Press

    Jun 15, 2018

    ThinkCyte Publishes Paper on “Ghost Cytometry” Method in Science

  • Press

    Jun 15, 2018

    ThinkCyte Completes Seed Financing

THINKCYTE Get in touch

Science

Platform
  • Cell Therapy
  • Drug Discovery /
    Functional Genomics
Resources
  • Documentation
  • Publications

Company

  • Mission
  • Team
  • News
  • Careers

ThinkCyte Inc.

United States
733 Industrial Road, San Carlos, CA 94070

Japan
7-3-1 Hongo, Bunkyo, Tokyo

© THINKCYTE inc. All rights reserved. Do not use or reproduce without permission.

Privacy Policy